Psychiatric Medications for Deployment

Ec, Ritchie

doi:10.1093/milmed/159.10.647

Cited by 9 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Sentiment began to shift in the mid‐1990s with the development of “cleaner” psychiatric drugs, namely SSRIs. Drawing on her experience in peacekeeping operations in Somalia during the early 1990s, Army psychiatrist Elspeth Ritchie () was the first to propose a “psychiatric sick call chest” for both psychiatric emergencies and for chronic treatment of depression and anxiety. While those like Ritchie advocated for psychiatric medications to avoid damaging military careers with unnecessary removals from operational duty, skeptics warned that the safety of SSRIs in combat had not been proven.…”

Section: Master Of His Own Anxiety: the Pre‐9/11 Unmedicated Soldiermentioning

confidence: 99%

Pharmaceutical Creep: U.S. Military Power and the Global and Transnational Mobility of Psychopharmaceuticals

Chua

2020

Med Anthropol Q

View full text Add to dashboard Cite

In 2006, the United States Department of Defense developed for the first time official criteria for the use of psychopharmaceuticals "in theater"-in the physical and tactical spaces of military operations including active combat. Based on fieldwork with Army soldiers and veterans, this article explores the transnational and global dimensions of military psychopharmaceutical use in the post-9/11 wars. I consider the spatial, material, and symbolic dimensions of what I call "pharmaceutical creep"-the slow drift of psychopharmaceuticals from the civilian world into theater and into the military corporate body. While pharmaceutical creep is managed by the U.S. military as a problem of gatekeeping and of supply and provisioning, medications can appear as the solution to recruitment and performance problems once in theater. Drawing on soldiers' accounts of medication use, I illuminate the possibilities, but also the frictions, that arise when routine psychopharmaceuticals are remade into technologies of global counterinsurgency. [global pharmaceuticals, psychiatric medications, psychiatry, U.S. military, U.S. empire]

show abstract

Section: Master Of His Own Anxiety: the Pre‐9/11 Unmedicated Soldiermentioning

confidence: 99%

Pharmaceutical Creep: U.S. Military Power and the Global and Transnational Mobility of Psychopharmaceuticals

Chua

2020

Med Anthropol Q

View full text Add to dashboard Cite

show abstract

“…The most common psychotropic drug classes include antipsychotics, antidepressants, anti-anxiety agents, Benzodiazepines (BZD), stimulants and mood stabilisers. 8 Among the various antipsychotics prescribed, both First Generation Antipsychotics (FGA) and Second Generation Antipsychotics (SGA) show Dopamine D2 Receptor (D2R) blockade. However, SGA shows predominant 5-Hydroxy-Tryptamine-2A (5-HT2A) receptor blockade as well.…”

Section: Introductionmentioning

confidence: 99%

Risk of Respiratory Diseases with Use of Psychotropic Drugs: Results of a Community-based Cross-sectional Study from South India

Eby,

Dang,

Jacob

2023

Ind. J. Pharm. Edu. Res

View full text Add to dashboard Cite

Background:The study evaluated the effect of various psychotropics on pulmonary function to identify the psychotropic drug class most commonly associated with risk of respiratory disorders. Since psychotropic medications have safety concerns for usage in general population, their use in people with Coronavirus Disease (COVID-19) is considered challenging. The study may also serve to draw evidence-based practical recommendations for the treatment of people with COVID-19. Materials and Methods: A 10-item containing questionnaire was designed to capture clinical information regarding psychotropic use and respiratory disorders. Internal consistency and reproducibility were determined using Cronbach's alpha and intra-class correlation coefficient respectively. A validated questionnaire was administered to patients or caregivers at a community pharmacy setup and data was collected through electronic data capture. All captured data were summarized descriptively and statistically analyzed using R Studio 4.0. Results: Cronbach's alpha and intra-class correlation coefficient values were found to be 0.92 and 0.85 respectively. In a sample of 198 patients, benzodiazepines were the commonly used medication (43.9%) followed by selective serotonin reuptake inhibitors (21.2%), anti-psychotics (15.1%), mood stabilizers (7.6%) and others (12.2%). A statistically significant association was observed between benzodiazepine, second-generation antipsychotics, and respiratory disorders p<0.1]). However, the use of first-generation antipsychotics was found to be less associated with respiratory infections. Conclusion: Benzodiazepine and second-generation antipsychotics were found to be significantly associated with respiratory disorders. Hence patients on psychotropics should be monitored for respiratory symptoms and the choice of anti-psychotic medications should be on existing clinical evidence. The psychotropics which were found to be safer through the study can be chosen to improve the quality of psychiatric care in COVID-19 patients, also promoting an optimal management of psychiatric conditions without worsening the medical condition due to COVID-19.

show abstract

Updates in Psychopharmacology for PTSD and Related Conditions: Focus on the Active Duty Service Member

Ritchie

Nelson

2015

Posttraumatic Stress Disorder and Related Diseases in Combat Veterans

View full text Add to dashboard Cite

Psychiatric Medications for Deployment

Cited by 9 publications

References 0 publications

Pharmaceutical Creep: U.S. Military Power and the Global and Transnational Mobility of Psychopharmaceuticals

Pharmaceutical Creep: U.S. Military Power and the Global and Transnational Mobility of Psychopharmaceuticals

Risk of Respiratory Diseases with Use of Psychotropic Drugs: Results of a Community-based Cross-sectional Study from South India

Updates in Psychopharmacology for PTSD and Related Conditions: Focus on the Active Duty Service Member

Contact Info

Product

Resources

About